BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28782758)

  • 1. Mechanism of C5a-induced immunologic derangement in sepsis.
    Xu R; Lin F; Bao C; Wang FS
    Cell Mol Immunol; 2017 Sep; 14(9):792-793. PubMed ID: 28782758
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo biological responses in the presence or absence of C3.
    Sarma JV; Ward PA
    Adv Exp Med Biol; 2007; 598():240-50. PubMed ID: 17892216
    [No Abstract]   [Full Text] [Related]  

  • 4. The dark side of C5a in sepsis.
    Ward PA
    Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
    Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
    J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation during sepsis in humans.
    Schreiber H; Rittirsch D; Flierl M; Brueckner U; Schneider M; Weiss M; Gebhard F; Huber-Lang M
    Adv Exp Med Biol; 2006; 586():217-26. PubMed ID: 16893075
    [No Abstract]   [Full Text] [Related]  

  • 9. A key role of C5a/C5aR activation for the development of sepsis.
    Riedemann NC; Guo RF; Ward PA
    J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
    Fattahi F; Zetoune FS; Ward PA
    Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
    Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
    J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
    FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of innate immunity by C5aR antagonist in septic mice.
    Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
    FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
    Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
    FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.
    Denk S; Taylor RP; Wiegner R; Cook EM; Lindorfer MA; Pfeiffer K; Paschke S; Eiseler T; Weiss M; Barth E; Lambris JD; Kalbitz M; Martin T; Barth H; Messerer DAC; Gebhard F; Huber-Lang MS
    Scand J Immunol; 2017 Sep; 86(3):143-155. PubMed ID: 28671713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of low-dose endotoxin to healthy humans increases C5a binding to circulating neutrophils.
    Granowitz EV; Porat R; Gelfand JA; Wolff SM; Dinarello CA
    J Infect Dis; 1994 Feb; 169(2):480-2. PubMed ID: 8106792
    [No Abstract]   [Full Text] [Related]  

  • 18. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
    Sadik CD; Miyabe Y; Sezin T; Luster AD
    Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of delta annexin A3 in the ribosomal protein S19 C-terminus-dependent inhibitory mechanism of the neutrophil C5a receptor through delta lactoferrin.
    Yamanegi K; Yamada N; Nakasho K; Nishiura H
    Pathol Int; 2018 Feb; 68(2):109-116. PubMed ID: 29288518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of C5a in inflammatory responses.
    Guo RF; Ward PA
    Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.